GOSSELIES, Wallonia, Belgium, March 13, 2024 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces the launch of BIOCERA-VET® Equine in countries already covered by the Company.
Retaining of a leading consulting firm with a solid track record of upscaling vet companies on the US marketTo rapidly expand TheraVet presence and be recognized as a major player in the US orthopedics marketTo assess possibilities to gain critical market size through potential merger and acquisition options for The.
TheraVet Reports an 99% Increase in BIOCERA-VET Units Sold in Q4 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
GOSSELIES, Belgium & WALLONIA, Belgium, January 17, 2024 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET) (Paris:ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces today the commercial launch of its BIOCERA-VET® products in Germany.
TheraVet: Agreement with Alcyon Italia for the Distribution of BIOCERA-VET® Product Line in Italy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.